Search - tctmd.com

Displaying 701 - 720 of 7861

Sort: Relevancy | Date

Presentation TCT 2024

TCT 132: Impact of Comorbid Heart Failure With Reduced Ejection Fraction (HFrEF) in the Development of Arrhythmias Among Patients Hospitalized for Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Bruce Adrian Casipit

October 29, 2024

Presentation TCT 2024

TCT 128: TAVI/TAVR Device Capable of Heart Rhythm Pacing & Resynchronization Therapy

Presenter: Eric Rytkin

October 29, 2024

Presentation TCT 2024

Case-Based Examples – When TEER Is Challenging and Managing Complications (e.g. SLDA)

Presenter: Bassem Chehab

October 29, 2024

Presentation TCT 2024

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Presenter: Samir Kapadia

October 29, 2024

Presentation TCT 2024

Case-Based Examples – Primary MR, Green Zone Anatomy (Including Optimizing the Transseptal Puncture)

Presenter: Michael Young

October 29, 2024

Presentation TCT 2024

The Cardiovalve TTVR Clinical Program

Presenter: Christian Frerker

October 29, 2024

Presentation TCT 2024

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Presenter: Didier Tchetche

October 29, 2024

Presentation TCT 2024

Case-Based Examples – Complex Primary MR, Yellow Zone Anatomy (Including Device Selection)

Presenter: Mirjam Wild

October 29, 2024

Presentation TCT 2024

TCT 789: Sex-Specific Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

October 29, 2024

Presentation TCT 2024

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Presenter: Tobias Rheude

October 29, 2024

Presentation TCT 2024

Case 2: Device Choice for TR When RV Leads Are Present

Presenter: Christian Besler

October 29, 2024

Presentation TCT 2024

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

Presenter: Thomas Pilgrim

October 29, 2024

Presentation TCT 2024

Case 1: Atrial Functional TR - Preferred Device Choices

Presenter: Mirjam Wild

October 29, 2024

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

Case-Based Examples – Secondary Mitral Regurgitation (Including Technical Tips and Tricks)

Presenter: Ralph von Bardeleben

October 29, 2024

Presentation TCT 2024

TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial

Presenter: Pieter Smits

October 29, 2024

Presentation TCT 2024

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Presenter: Usman Akbar

October 29, 2024

Presentation TCT 2024

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

Presenter: José Antonio Baz Alonso

October 29, 2024

Presentation TCT 2024

Patient Selection for Mitral TEER (An Imaging Focus) - Who Can’t We Treat?

Presenter: Geraldine Ong

October 29, 2024

Presentation TCT 2024

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

Presenter: Ricky E Lemus-Zamora

October 29, 2024

Advertisement

TCT 132: Impact of Comorbid Heart Failure With Reduced Ejection Fraction (HFrEF) in the Development of Arrhythmias Among Patients Hospitalized for Transcatheter Aortic Valve Replacement (TAVR)

TCT 128: TAVI/TAVR Device Capable of Heart Rhythm Pacing & Resynchronization Therapy

Case-Based Examples – When TEER Is Challenging and Managing Complications (e.g. SLDA)

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Case-Based Examples – Primary MR, Green Zone Anatomy (Including Optimizing the Transseptal Puncture)

The Cardiovalve TTVR Clinical Program

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Case-Based Examples – Complex Primary MR, Yellow Zone Anatomy (Including Device Selection)

TCT 789: Sex-Specific Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Case 2: Device Choice for TR When RV Leads Are Present

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

Case 1: Atrial Functional TR - Preferred Device Choices

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Case-Based Examples – Secondary Mitral Regurgitation (Including Technical Tips and Tricks)

TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

Patient Selection for Mitral TEER (An Imaging Focus) - Who Can’t We Treat?

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content